Mark Connor

8.7k total citations
135 papers, 6.5k citations indexed

About

Mark Connor is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Mark Connor has authored 135 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Cellular and Molecular Neuroscience, 74 papers in Molecular Biology and 50 papers in Pharmacology. Recurrent topics in Mark Connor's work include Cannabis and Cannabinoid Research (48 papers), Neuroscience and Neuropharmacology Research (38 papers) and Neuropeptides and Animal Physiology (34 papers). Mark Connor is often cited by papers focused on Cannabis and Cannabinoid Research (48 papers), Neuroscience and Neuropharmacology Research (38 papers) and Neuropeptides and Animal Physiology (34 papers). Mark Connor collaborates with scholars based in Australia, United States and New Zealand. Mark Connor's co-authors include MacDonald J. Christie, Christopher W. Vaughan, Samuel D. Banister, Susan Ingram, Michelle Glass, Iain S. McGregor, Elena E. Bagley, Christopher Bailey, Graeme Henderson and Michael Kassiou and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Mark Connor

133 papers receiving 6.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Connor Australia 46 3.6k 2.8k 2.2k 1.5k 1.0k 135 6.5k
William L. Dewey United States 45 4.3k 1.2× 3.1k 1.1× 2.4k 1.1× 2.5k 1.7× 391 0.4× 279 7.7k
Mary E. Abood United States 52 4.5k 1.3× 2.7k 0.9× 6.7k 3.0× 667 0.5× 854 0.8× 130 9.1k
Jeffrey M. Witkin United States 49 5.2k 1.5× 3.1k 1.1× 1.5k 0.7× 622 0.4× 251 0.2× 231 7.4k
Małgorzata Filip Poland 46 4.5k 1.3× 3.4k 1.2× 1.2k 0.5× 809 0.5× 224 0.2× 264 7.6k
Dana E. Selley United States 45 4.7k 1.3× 2.9k 1.0× 3.7k 1.7× 1.2k 0.8× 635 0.6× 142 7.5k
James H. Woods United States 47 4.5k 1.3× 2.9k 1.0× 871 0.4× 1.2k 0.8× 703 0.7× 217 6.7k
Alessia Ligresti Italy 46 2.4k 0.7× 1.4k 0.5× 5.6k 2.5× 849 0.6× 451 0.4× 126 7.5k
Ruth A. Ross United Kingdom 45 4.5k 1.3× 2.0k 0.7× 7.9k 3.5× 1.1k 0.7× 677 0.7× 111 9.8k
Stephen J. Peroutka United States 56 7.4k 2.1× 5.0k 1.8× 1.3k 0.6× 1.8k 1.2× 459 0.4× 156 12.2k
Christian C. Felder United States 65 7.8k 2.2× 7.3k 2.6× 5.0k 2.2× 1.2k 0.8× 658 0.6× 158 14.0k

Countries citing papers authored by Mark Connor

Since Specialization
Citations

This map shows the geographic impact of Mark Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Connor more than expected).

Fields of papers citing papers by Mark Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Connor. The network helps show where Mark Connor may publish in the future.

Co-authorship network of co-authors of Mark Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Connor. A scholar is included among the top collaborators of Mark Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Connor. Mark Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Connor, Mark, et al.. (2024). A ruler detection method for auto-adjusting scales of shoeprint images. Science & Justice. 64(5). 498–508. 1 indexed citations
2.
Bladen, Chris, et al.. (2021). Modulation of Recombinant Human T-Type Calcium Channels by Δ 9 -Tetrahydrocannabinolic Acid In Vitro. Cannabis and Cannabinoid Research. 7(1). 34–45. 8 indexed citations
3.
Heblinski, Marika, Marina Santiago, Jordyn Stuart, et al.. (2020). Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels. Cannabis and Cannabinoid Research. 5(4). 305–317. 47 indexed citations
4.
Moir, Michael, et al.. (2020). The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonist. European Journal of Medicinal Chemistry. 210. 113087–113087. 3 indexed citations
5.
Sachdev, Shivani, Kiran Vemuri, Samuel D. Banister, et al.. (2019). In vitro determination of the efficacy of illicit synthetic cannabinoids at CB 1 receptors. British Journal of Pharmacology. 176(24). 4653–4665. 39 indexed citations
6.
Santiago, Marina, et al.. (2019). Cannabichromene is a cannabinoid CB 2 receptor agonist. British Journal of Pharmacology. 176(23). 4537–4547. 80 indexed citations
7.
Santiago, Marina, Shivani Sachdev, Jonathon C. Arnold, Iain S. McGregor, & Mark Connor. (2019). Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ 9 -THC at Human CB 1 and CB 2 Receptors. Cannabis and Cannabinoid Research. 4(3). 165–176. 86 indexed citations
8.
Banister, Samuel D., Axel Adams, Richard C. Kevin, et al.. (2018). Synthesis and pharmacology of new psychoactive substance 5F‐CUMYL‐P7AICA, a scaffold‐ hopping analog of synthetic cannabinoid receptor agonists 5F‐CUMYL‐PICA and 5F‐CUMYL‐PINACA. Drug Testing and Analysis. 11(2). 279–291. 47 indexed citations
10.
McDougall, Stuart J., Britt A. Berning, Delfine Cheng, et al.. (2017). Polysialic Acid Regulates Sympathetic Outflow by Facilitating Information Transfer within the Nucleus of the Solitary Tract. Journal of Neuroscience. 37(27). 6558–6574. 6 indexed citations
11.
Fioretti, Bernard, Luigi Catacuzzeno, Luigi Sforna, et al.. (2011). Trigeminal ganglion neuron subtype‐specific alterations of CaV2.1 calcium current and excitability in a Cacna1a mouse model of migraine. The Journal of Physiology. 589(23). 5879–5895. 48 indexed citations
12.
Connor, Mark, et al.. (2008). Sumatriptan Inhibits Synaptic Transmission in the Rat Midbrain Periaqueductal Grey. Molecular Pain. 4. 54–54. 38 indexed citations
13.
Connor, Mark, et al.. (2007). Lack of functional expression of NMDA receptors in PC12 cells. NeuroToxicology. 28(4). 876–885. 42 indexed citations
14.
Connor, Mark, Stephanie L. Borgland, & MacDonald J. Christie. (1999). Continued morphine modulation of calcium channel currents in acutely isolated locus coeruleus neurons from morphine‐dependent rats. British Journal of Pharmacology. 128(7). 1561–1569. 38 indexed citations
15.
Connor, Mark, Christopher W. Vaughan, Ernest Jennings, Richard G. Allen, & MacDonald J. Christie. (1999). Nociceptin, Phe1ψ‐nociceptin1–13, nocistatin and prepronociceptin154–181 effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro. British Journal of Pharmacology. 128(8). 1779–1787. 37 indexed citations
16.
Connor, Mark, et al.. (1997). δ-opioid Receptor Mobilization of Intracellular Calcium in SH-SY5Y Cells: Lack of Evidence for δ-receptor Subtypes. Neuropharmacology. 36(1). 125–133. 20 indexed citations
17.
Fletcher, Jamie I., Ross Smith, Séan O’Donoghue, et al.. (1997). The structure of a novel insecticidal neurotoxin, ω-atracotoxin-HV1, from the venom of an Australian funnel web spider. Nature Structural Biology. 4(7). 559–566. 156 indexed citations
18.
Connor, Mark, et al.. (1997). Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH‐SY5Y human neuroblastoma cells. British Journal of Pharmacology. 120(3). 455–463. 27 indexed citations
19.
Nicholson, Graham M., et al.. (1991). Frequency-dependent neuromuscular blockade by textilotoxin in vivo. Toxicon. 29(10). 1266–1269. 5 indexed citations
20.
Connor, Mark & Charles Chavkin. (1991). Focal stimulation of specific pathways in the rat hippocampus causes a reduction in radioligand binding to the haloperidol-sensitive sigma receptor. Experimental Brain Research. 85(3). 528–36. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026